Choose region and then country

Africa

America

Asia

Europe

Oceania

Other Lundbeck sites

Global contacts

We operate in more than 57 countries around the world. If your country is not on the list, please refer to our global contacts.

View contacts


Antidepressant
	Cipralex^®	Product Monograph	Patient Information	Communication
	Celexa^®	Product Monograph	Patient Information	HCP Communication 2004 HCP Communication 2012 Public communication 2012

Antipsychotics
	Clopixol^®	Product Monograph	Patient Information	Communication
	Clopixol Acuphase^®	Product Monograph	Patient Information	Communication
	Clopixol Depot^®	Product Monograph	Patient Information	Communication
	Fluanxol^®	Product Monograph	Patient Information	Communication
	Fluanxol Depot^®	Product Monograph	Patient Information	Communication
	Saphris™	Product Monograph	Patient Information

Alzheimer's
	Ebixa^®	Product Monograph	Patient Information	Communication

*Ebixa® is a registered trademark of Merz Pharma GmbH, under license to Lundbeck Canada Inc.

The Saphris™ trademark is used under license from N.V. Organon, a subsidiary of Merck & Co., Inc.,Whitehouse Station,NJ,USA

The product monographs provided here are identical to those posted on Health Canada's website with the exception of the removal of those strengths and/or presentations which are not currently available on the Canadian market as well as Lundbeck Canada's updated address information.

You are now leaving www.lundbeck.ca , Lundbeck Canada’s Web site. Links to site outside of Lundbeck Canada are provided as resources to visitors and may not represent Canada regulation or prescribing information. Lundbeck Canada accepts no responsibility in the content of linked sites.

Choose region and then country

Other Lundbeck sites

Global contacts

Our products

Here you will find information that is provided to consumers and health care providers on each of our Lundbeck Canada Inc. products to encourage correct usage.